The Institute of Chemical Research of Catalonia (ICIQ) is a public foundation that started its research activities in 2004. ICIQ is committed with performing research at the frontiers of knowledge in the field of chemistry, the two main research areas are: Catalysis and Renewable Energy. Currently ICIQ hosts more than 340 employees, 83% of them being researchers recruited worldwide. The institute is sponsored by leading chemical and pharmaceutical companies and it is funded by the Generalitat de Catalunya, the European Union (FEDER funds), as well as, by competitive research projects and the revenues from industrial collaborations. Its leadership in Chemical Research has been demonstrated by the high ratio of ERC awardees (7 out of the 19 Principal Investigators), in addition ICIQ has been recognized as “Severo Ochoa Centre of Excellence” by the Spanish Ministry of Economy and Competitiveness.
AiCuris is a biotech company (spin-out from Bayer’s Antiinfective Department in 2006, www.aicuris.com). AiCuris develops new small molecule antiviral and antibacterial agents with new mode-of-actions and/or from new chemical classes, which are therefore resistance-breaking by design. AiCuris focuses mainly in life-threatening diseases.
Entgeltgruppe 34,893 €/ year
VIRO-FLOW is a recently funded Horizon 2020 project that aims to integrate the advantages of continuous flow chemical synthesis with in vitro microfluidic bioassay technologies for the fast and efficient discovery of inhibitors of hepatitis B virus (HBV). www.viro-flow.eu
The research programme is composed of three closely related projects in the fields of medicinal chemistry, molecular biology/ protein biochemistry and computational chemistry, and will provide exceptional training in drug discovery and enabling technologies for three Early-Stage Researchers (ESRs).
The ESRs will be supported by a network of experts at AiCuris, an infectious disease-focused biotech company, and the Institute of Chemical Research of Catalonia (ICIQ), a research center working on catalysis, with a special focus on sustainability (functionalization of small molecules, renewable energies, new uses for light in chemistry) using an integrated approach. ICIQ is highly committed to knowledge and technology transfer to the chemical, pharmaceutical and energy industrial sectors.
The ESR training will include international, interdisciplinary and inter-sectorial mobility, and will integrate academic and industrial contributions.
VIRO-FLOW is funded by the European Union’s Framework Programme for Research and Innovation Horizon 2020 (2014-2020) under the Marie Sklodowska-Curie Grant Agreement No. 766058.
ICIQ and AiCuris
Av. Països Catalanes 16